The purpose of this memo is to cover the upcoming changes to Gilead Science's Advancing Access® Patient Assistance and Co-pay Assistance Programs, and to identify the impact these changes will have on PrEP-AP clients.
Gilead's company statement released on April 8, 2021, announced changes to their Advancing Access® Patient Assistance and Co-pay Assistance Program medication delivery model. In a Gilead company statement released on April 9, 2021, they announced these changes would be implemented starting January 1, 2022. For all Advancing Access® program participants, Gilead will offer two options: 1) direct delivery via an overnight shipping service to an address of choice, or 2) retail pharmacy pickup. Gilead will implement a change in their retail pharmacy model, requiring dispensing pharmacies to contract with AssistRx. These AssistRx network pharmacies will be reimbursed the amount paid for each bottle of Truvada® or Descovy® plus a dispensing fee and an administrative fee. If a pharmacy has questions about how to contract with AssistRx, they can reach out directly to GileadSupportProgram@assistrx.com for assistance.
The updates to Advancing Access® will change how some PrEP-AP clients access their PrEP medications. PrEP-AP clients who use the Advancing Access® Patient Assistance or Co-pay Assistance Programs to access Truvada® or Descovy® will need to arrange for direct delivery of their medication to an address of their choice, or pick up their Truvada® or Descovy® at an AssistRx pharmacy. PrEP-AP clients who do not use the Advancing Access® program to access their PrEP medication will continue to pick up their PrEP prescriptions at a MagellanRx Network Pharmacy. All PrEP-AP clients will continue to pick up medications on the PrEP-AP Formulary (PDF) other than Truvada® or Descovy® at a MagellanRx Network Pharmacy. For PrEP-AP clients that will experience changes to their PrEP access, clinical providers will need to send the client's PrEP prescription to an AssistRx pharmacy, or fax the prescription to the AssistRx mail order pharmacy at 913-227-4203 to facilitate establishing direct delivery of the medication. For new PrEP-AP clients who are Advancing Access® program participants, section 10 of the Advancing Access® Patient Enrollment Form (PDF) will determine how the client accesses their medication.
- Uninsured clients
- Medicare clients without Part D drug coveragenew page
- Some insured clients (if they are enrolled in the Advancing Access® Co-pay Assistance Program because their insurance does not cover PrEP)
- Most insured clients (if their insurance covers PrEP)
- Medicare clients with Part D drug coverage
- Minor clients
- Clients with confidentiality concerns
PrEP-AP uninsured clients and Medicare clients without Part D coverage are enrolled in the Advancing Access® Patient Assistance Program, and will need to arrange for direct delivery of their Truvada® or Descovy®, or pick up their prescription at an AssistRx pharmacy. PrEP-AP insured clients whose insurance does not cover PrEP are enrolled in the Advancing Access® Co-pay Assistance Program and will also need to access their Truvada® or Descovy® through direct delivery, or pick up their prescription at an AssistRx pharmacy.
Most PrEP-AP insured clients, as well as minor clients, clients with confidentiality concerns, and Medicare clients with Part D coverage are not enrolled in an Advancing Access® program, and will continue to pick up their prescriptions at a MagellanRx Network Pharmacy.
PrEP-AP clients who would like to set up direct delivery of their prescription can call Advancing Access®: 1-800-226-2056, M-F 6AM-5PM PST. PrEP-AP clients who set up direct delivery for their prescription will receive their medication in plain packaging from FedEx, and also have the option to pick up their package from a nearby FedEx pickup location. PrEP-AP clients who need to find an AssistRx pharmacy in 2022 can call Advancing Access® at the number provided above in December 2021 to be directed to a nearby pharmacy location. An AssistRx pharmacy finder will be available on the Advancing Access® website on January 11, 2022.
PrEP-AP requests that you share this information with your PrEP-AP clients who are enrolled in a Gilead Advancing Access® program, as well as your clinical and leadership teams before January 2022.
If you have any questions regarding the changes to the Gilead Advancing Access Programs, please contact Advancing Access® at 1-800-226-2056, or PrEP-AP at.
Sharisse Kemp, MSW
ADAP Branch Chief
California Department of Public Health